Freenome launches lung cancer trial ahead of FDA approval bid
The study, named PROACT LUNG Lung, is looking to enroll 20,000 participants at up to 100 sites across the UK to validate the accuracy of its lung cancer test.
13 December 2023
13 December 2023
The study, named PROACT LUNG Lung, is looking to enroll 20,000 participants at up to 100 sites across the UK to validate the accuracy of its lung cancer test.
The transaction is expected to be completed in the first quarter of next year.
The 3D printing medical market is set to increase from $2bn in 2022, to over $4bn in 2026.
BillionToOne will supply prenatal foetal antigen tests as a screening assay in the Phase III AZALEA trial investigating Johnson & Johnson (J&J)’s nipocalimab.
The system can be easily integrated into a compact desktop robotic fluid handling automation system.
Hippo and Cheetah work together to provide speed, precision, and integration in thrombectomy procedures.
The Eagle device is designed for use in performing selective laser trabeculoplasty.
The iLet bionic pancreas is an autonomous insulin delivery system that simplifies diabetes management
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Cybersecurity is a growing market in the medical devices sector for several reasons. Medical devices often collect and contain vulnerable data, such as patient medical information. Legacy medical devices are a cause for concern because they likely were not designed with cyberattacks in mind. With the adoption of EHR systems, telemedicine measures, mobile health apps, and other connected devices, there is increased vulnerability to cyberattacks.
Give your business an edge with our leading industry insights.